Brazil Cell & Gene Therapy Third-party Logistics Market Size & Outlook

The cell & gene therapy third-party logistics market in Brazil is expected to reach a projected revenue of US$ 1,141.3 million by 2030. A compound annual growth rate of 10.7% is expected of Brazil cell & gene therapy third-party logistics market from 2025 to 2030.
Revenue, 2024 (US$M)
$620.6
Forecast, 2030 (US$M)
$1,141.3
CAGR, 2025 - 2030
10.7%
Report Coverage
Brazil

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Brazil cell & gene therapy third-party logistics market, 2018-2030 (US$M)

Brazil cell & gene therapy third-party logistics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Brazil cell & gene therapy third-party logistics market highlights

  • The Brazil cell & gene therapy third-party logistics market generated a revenue of USD 620.6 million in 2024 and is expected to reach USD 1,141.3 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 10.7% from 2025 to 2030.
  • In terms of segment, clinical was the largest revenue generating type in 2024.
  • Commercial is the most lucrative type segment registering the fastest growth during the forecast period.


Cell & gene therapy third-party logistics market data book summary

Market revenue in 2024USD 620.6 million
Market revenue in 2030USD 1,141.3 million
Growth rate10.7% (CAGR from 2025 to 2030)
Largest segmentClinical
Fastest growing segmentCommercial
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical, Commercial


Other key industry trends

  • In terms of revenue, Brazil accounted for 5.8% of the global cell & gene therapy third-party logistics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil cell & gene therapy third-party logistics market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 1,141.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Cell & Gene Therapy Third-Party Logistics Market Companies

Name Profile # Employees HQ Website
Knipper View profile 11-50 Saarbrücken, Saarland, Germany, Europe https://knipper.de
Arvato View profile 10001+ Arras, Nord-Pas-de-Calais, France, Europe https://arvato.fr/
Kuehne and Nagel View profile - - -
United Parcel Service of America, Inc. View profile - - -
McKesson Corporation View profile - - -
EVERSANA View profile 5001-10000 Milwaukee, Wisconsin, United States, North America https://www.eversana.com
Cencora Inc View profile 46000 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 https://www.cencora.com
FedEx Corp View profile 787400 942 South Shady Grove Road, Memphis, TN, United States, 38120 https://www.fedex.com
DHL Group View profile 594396 Platz der Deutschen Post, Bonn, NW, Germany, 53250 http://www.dpdhl.com
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com

Brazil cell & gene therapy third-party logistics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy third-party logistics market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 92.07% in 2024. Horizon Databook has segmented the Brazil cell & gene therapy third-party logistics market based on clinical, commercial covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Brazil cell & gene therapy third-party logistics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Brazil cell & gene therapy third-party logistics market databook

  • Our clientele includes a mix of cell & gene therapy third-party logistics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil cell & gene therapy third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into Brazil cell & gene therapy third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Brazil cell & gene therapy third-party logistics market size, by type, 2018-2030 (US$M)

Brazil Cell & Gene Therapy Third-Party Logistics Market Outlook Share, 2024 & 2030 (US$M)

Brazil cell & gene therapy third-party logistics market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online